Literature DB >> 6112515

Acute blood-pressure-lowering effect of ketanserin.

J De Cree, H Verhaegen, J Symoens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112515     DOI: 10.1016/s0140-6736(81)92331-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of alpha-adrenoceptor antagonists.

Authors:  R Donnelly; P A Meredith; H L Elliott
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

2.  Bioavailability and pharmacokinetics of ketanserin in elderly subjects.

Authors:  M Kurowski
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Role of endogenous serotonin in the regulation of blood pressure in patients with chronic renal failure.

Authors:  M Yamakado; M Nagano; M Umezu; H Tagawa; H Kiyose
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration.

Authors:  J Heykants; A Van Peer; R Woestenborghs; S Gould; J Mills
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-ol.

Authors:  A Van Peer; R Woestenborghs; L Embrechts; J Heykants
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Pharmacokinetics of ketanserin in man.

Authors:  I W Reimann; P O Okonkwo; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Acute effects of ketanserin on left ventricular function, metabolism and coronary blood flow.

Authors:  J M Walker; P T Wilmshurst; S M Juul; D J Coltart
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

8.  Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

Authors:  G J Wenting; A J Man in 't Veld; A J Woittiez; F Boomsma; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

9.  Pharmacokinetics of ketanserin in patients with essential hypertension.

Authors:  B Persson; A Pettersson; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.

Authors:  R Fagard; R Fiocchi; P Lijnen; J Staessen; E Moerman; A de Schaepdryver; A Amery
Journal:  Br Heart J       Date:  1984-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.